Emergence of antiretroviral drug resistance in therapy-naive HIV infected patients in Hungary

Acta Microbiologica et Immunologica Hungarica

Volumn 55, Issue 4, 2008, Pages 383-394

  Juhsz, Emese ^a   Ghidn, A ^a   Kemny, B ^b   Nagy, K ^a  

^a SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

^b National Institute of Dermato Venerology   (Hungary)

Author keywords

Genotyping; HIV 1 drug resistant mutants; Nucleoside analogue reverse transciptase inhibitors; Therapy naive HIV infected patients

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 57349128868     PISSN: 12178950     EISSN: 15882640     Source Type: Journal    
DOI: 10.1556/AMicr.55.2008.4.3     Document Type: Article

References (34)

1. L. M. Mansky 1998 Retrovirus mutation rates and their role in genetic variation J Gen Virol 79 1337 1345
2. F. Clavel A. J. Hance 2004 Medical progress: HIV drug resistance N Engl J Med 350 1023 1035
3. V. Simon D. D. Ho Q. A. Karim 2006 HIV/AIDS epidemiology, pathogenesis, prevention, and treatment Lancet 368 489 504
4. L. M. Mansky H. M. Temin 1995 Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse-transcriptase J Virol 69 5087 5094
5. A. S. Perelson A. U. Neumann M. Markowitz J. M. Leonard D. D. Ho 1996 HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time Science 271 1582 1586
6. L. Kils-Hutten R. Cheynier S. Wain-Hobson A. Meyerhans 2001 Phylogenetic reconstruction of intrapatient evolution of human immunodeficiency virus type 1: predominance of drift and purifying selection J Gen Virol 82 1621 1627
7. D. N. Levy G. M. Aldrovandi O. Kutsch G. M. Shaw 2004 Dynamics of HIV-1 recombination in its natural target cells Proc Natl Acad Sci U S A 101 4204 4209
8. G. W. Suryavanshi N. M. Dixit 2007 Emergence of recombinant forms of HIV: dynamics and scaling PLoS Comput Biol 3 e205
9. J. Chen Q. Dang D. Unutmaz V. K. Pathak F. Maldarelli D. Powell W.-S. Hu 2005 Mechanisms of nonrandom human immunodeficiency virus type 1 infection and double infection: preference in virus entry is important but is not the sole factor J Virol 79 4140 4149
10. T. Rhodes H. Wargo W.-S. Hu 2003 High rates of human immunodeficiency virus type 1 recombination: near-random segregation of markers one kilobase apart in one round of viral replication J Virol 77 11193 11200
11. C. Charpentier T. Nora O. Tenaillon F. Clavel A. J. Hance 2006 Extensive recombination among human immunodeficiency virus type 1 quasispecies makes an important contribution to viral diversity in individual patients J Virol 80 2472 2482
12. C. L. Althaus S. Bonhoeffer 2005 Stochastic interplay between mutation and recombination during the acquisition of drug resistance mutations in human immunodeficiency virus type 1 J Virol 79 13572 13578
13. K. Nagy M. Young C. Baboonian J. Merson P. Whittle S. Oroszlan 1994 Antiviral activity of human immunodeficiency virus type 1 protease inhibitors in a single cycle of infection: evidence for a role of protease in the early phase J Virol 68 757 765
14. J. Stephenson 2007 Researchers buoyed by novel HIV drugs: will expand drug arsenal against resistant virus JAMA 297 14 1535 1536
15. V. A. Johnson F. Brun-Vezinet B. Clotet D. R. Kuritzkes D. Pillay J. M. A. Schapiro D. D. Richman 2006 Update of the drug resistance mutations in HIV-1: fall 2006 Top. HIV Med 14 125 130
16. R. F. Schinazi B. A. Larder J. Mellors 2000 Mutations in retroviral genes associated to drug resistance: update 20002001 Int Antivir News 8 65 91
17. R. W. Shafer 2002 Genotypic testing for human immunodeficiency virus type 1 drug resistance Clin Microbiol Rev 15 247 277
18. W. J. Lech G. Wang Y. L. Yang Y. Chee K. Dorman D. McCrae L. C. Lazzeroni J. W. Erickson J. S. Sinsheimer A. H. Kaplan 1996 In vivo sequence diversity of the protease of human immunodeficiency virus type 1: presence of protease inhibitor-resistant variants in untreated subjects J Virol 70 2038 2043
19. R. M. Ribeiro S. Bonhoeffer 2000 Production of resistant HIV mutants during antiretroviral therapy Proc Natl Acad Sci U S A 97 7681 7686
20. J. T. Herbeck D. C. Nickle G. H. Learn G. S. Gottlieb M. E. Curlin L. Heath J. I. Mullins 2006 Human immunodeficiency virus type 1 env evolves toward ancestral states upon transmission to a new host J Virol 80 1637 1644
21. R. B. Markham W. C. Wang A. E. Weisstein Z. Wang A. Munoz A. Templeton J. Margolick D. Vlahov T. Quinn 1998 Patterns of HIV-1 evolution in individuals with differing rates of CD4 T cell decline Proc Natl Acad Sci U S A 95 12568 12573
22. Telesnitsky, A., Goff, S. P.: Reverse transcriptase and the generation of retroviral DNA. In: Coffin, J. M., Hughes, S. H., Varmus, H. E. (eds): Retroviruses. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, pp. 121160 (1997).
23. S. A. Clark N. S. Shulman R. J. Bosch J. W. Mellors 2006 Reverse transcriptase mutations 118I, 208Y, and 215Y cause HIV-1 hypersusceptibility to non-nucleoside reverse transcriptase inhibitors AIDS 20 981 984
24. N. S. Shulman R. J. Bosch J. W. Mellors M. A. Albrecht D. A. Katzenstein 2004 Genetic correlates of efavirenz hypersusceptibility AIDS 18 1781 1785
25. K. Van Laethem K. M. Witvrouw C. Pannecouque B. Van Remoortel J. C. Schmit R. Esnouf J. P. Kleim J. Balzarini J. Desmyter E. De Clercq A. M. Vandamme 2001 Mutations in the non-nucleoside binding-pocket interfere with the multi-nucleoside resistance phenotype AIDS 15 553 561
26. B. Kemny K. Nagy A. Horvth 2000 CCR5 and SDF1 gene polymorphism in HIV-infected and healthy individuals in Hungary Hung Vener Arch 4 23 89 92
27. S. Ibe J. Hattori S. Fujisaki U. Shigemi S. Fujisaki K. Shimizu K. Nakamura T. Kazumi Y. Yokomaku M. Mamiya M. Hamaguchi T. Kaneda 2008 Trend of drug-resistant HIV type 1 emergence among therapy-naive patients in Nagoya, Japan: An 8-year surveillance from 1999 to 2006 AIDS Research and Human Retroviruses 24 1 7 14
28. Wensing, A. M.: Systemic surveillance of transmission of HIV resistance in Europe. The SPREAD project. Inst Conf AIDS, Barcelona, TuPe5370 (2002).
29. O. Gallego C. Briones A. Corral V. Soriano 2000 Prevalence of novel lamivudine-resistant genotypes (E44D/A, V118I) in naive and pretreated HIV-infected individuals J Acquir Immune Defic Syndr 5 95 96
30. L. Stuyver A. Wyseur A. Rombout J. Louwagie T. Scarcez C. Verhofstede D. Rimland R. F. Schinazi R. Rossau 1997 Line probe assay for rapid detection of drug-selected mutations in the human immunodeficiency virus type 1 reverse transcriptase gene Antimicrob Agents Chemother 41 284 291
31. D. Boden A. Hurley L. Zhang 1999 HIV-1 drug resistance in newly infected individuals JAMA 282 1135 1141
32. J. Servais C. Lambert E. Fontaine J. M. Plesseria I. Robert V. Arendt T. Staub F. Schneider R. Hemmer C. Burtonboy J. C. Schmit 2001 Comparison of DNA sequencing and a line probe assay for detection of human immunodeficiency virus type 1 drug resistance mutations in patients failing highly active antiretroviral therapy J Clin Microbiol 39 454 459
33. M. C. Re P. Monari I. Bon D. Gibellini F. Vitone M. Borderi M. La Placa 2001 Analysis of HIV-1 drug resistant mutations by line probe assay and direct sequencing in a cohort of therapy naive HIV-1 infected Italian patients BMC Microbiology 1 30 35
34. M. C. Re P. Monari M. Borderi M. Tadolini G. Verucchi F. Vitone S. Spinosa M. La Placa 2001 Presence of genotypic resistance to anti-retroviral drugs in a cohort of therapy naive HIV-1 infected Italian patients J Acquir Immune Defic Syndr 27 315 316